TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Mochida Pharmaceutical Co., Ltd. ( (JP:4534) ) has issued an update.
Mochida Pharmaceutical Co., Ltd. announced the continuation of its Takeover Response Policy, originally approved in 2022, to protect against large-scale share acquisitions. The policy includes clarifications and expansions to ensure shareholder interests and corporate value are maintained. The company’s Board of Directors and Audit & Supervisory Board Members support the policy, which aims to provide sufficient information for shareholders to make informed decisions regarding potential acquisitions.
More about Mochida Pharmaceutical Co., Ltd.
Mochida Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the research, development, manufacturing, and sales of high-quality pharmaceutical products. Since its founding in 1913, the company has built a strong reputation and trust with business partners, customers, and local communities, emphasizing ongoing and stable research and development.
YTD Price Performance: -11.03%
Average Trading Volume: 26,864
Technical Sentiment Signal: Sell
Current Market Cap: Yen105.3B
For a thorough assessment of 4534 stock, go to TipRanks’ Stock Analysis page.